Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population

被引:8
作者
Gutierrez-Castaneda, Luz D. [1 ]
Gamboa, Mauricio [1 ]
Nova, John A. [1 ]
Pulido, Leonardo [1 ]
Tovar-Parra, Jose D. [1 ]
机构
[1] Hosp Univ, Ctr Dermatol Federico Lleras Acosta, CDFLLA, Bogota 111511, Colombia
关键词
CUTANEOUS MELANOMA; RISK-FACTORS; CLINICOPATHOLOGICAL CHARACTERISTICS; EPIDEMIOLOGY; FREQUENCIES; ACTIVATION; EXPRESSION; KINASE; CANCER; V600E;
D O I
10.1155/2020/2046947
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction. Mutations in the BRAF, NRAS, and C-KIT genes have been associated with the histopathological characteristics of melanoma. Likewise, the incidence of each of these subtypes changes according to the geographical origin of the population analyzed.Objective. To determine the mutation frequency in exons 11 and 15 of the BRAF gene, exons 1 and 2 of the NRAS gene, and exons 11, 13, and 17 of the C-KIT gene and to relate it with histological subtypes in patients from a region with high levels of ultraviolet radiation.Methodology. The clinicopathological characteristics of 54 cutaneous melanoma samples were analyzed. Mutation analysis was performed via qPCR on paraffin-embedded tumor tissue samples using probes specific for the V600E mutation. Amplification of exons 11 and 15 of the BRAF gene, exons 1 and 2 of the NRAS gene, and exons 11, 13, and 17 of the C-KIT gene was performed for subsequent sequencing using the Sanger method.Result. The most frequent histological subtype in the analyzed sample was lentigo maligna/lentigo maligna melanoma (52%) followed by acral lentiginous melanoma (20%). The BRAF-V600 variant was the most frequent (63.6%). The most frequent (54%) mutation in NRAS was p.Lys5*. In the C-KIT gene, only the Val560Ala mutation was found.Conclusion. Differences in histological subtypes and mutations in the BRAF, NRAS, and C-KIT genes were found in the analyzed population. This indicates that environmental and genetic factors significantly influence the introduction of the disease in this geographic region.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma
    Knol, Anne-Chantal
    Pandolfino, Marie-Christine
    Vallee, Audrey
    Nguyen, Frederique
    Lella, Virginie
    Khammari, Amir
    Denis, Marc
    Puaux, Anne-Laure
    Dreno, Brigitte
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (01) : 70 - 73
  • [22] The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort
    Ekedahl, H.
    Cirenajwis, H.
    Harbst, K.
    Carneiro, A.
    Nielsen, K.
    Olsson, H.
    Lundgren, L.
    Ingvar, C.
    Jonsson, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (05) : 1049 - 1055
  • [23] NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
    Tschandl, Philipp
    Berghoff, Anna Sophie
    Preusser, Matthias
    Burgstaller-Muehlbacher, Sebastian
    Pehamberger, Hubert
    Okamoto, Ichiro
    Kittler, Harald
    PLOS ONE, 2013, 8 (07):
  • [24] A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker
    Heinzelmann-Schwarz, Viola A.
    Nixdorf, Sheri
    Valadan, Mehrnaz
    Diczbalis, Monica
    Olivier, Jake
    Otton, Geoff
    Fedier, Andre
    Hacker, Neville F.
    Scurry, James P.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (04) : 784 - 794
  • [25] Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
    Schirosi, L.
    Nannini, N.
    Nicoli, D.
    Cavazza, A.
    Valli, R.
    Buti, S.
    Garagnani, L.
    Sartori, G.
    Calabrese, F.
    Marchetti, A.
    Buttitta, F.
    Felicioni, L.
    Migaldi, M.
    Rea, F.
    Di Chiara, F.
    Mengoli, M. C.
    Rossi, G.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2409 - 2414
  • [26] Targeted therapies in melanoma beyond BRAF: targeting NRAS-mutated and KIT-mutated melanoma
    Delyon, Julie
    Lebbe, Celeste
    Dumaz, Nicolas
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 79 - 84
  • [27] c-KIT in Uveal Melanoma Big Fish or Red Herring?
    Daniels, Anthony B.
    Abramson, David H.
    ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (05) : 695 - 697
  • [28] Mutation and expression of the C-KIT gene on population of Kazakhstan
    Khamdiyeva, O. K.
    Pack, S.
    Biyasheva, Z. M.
    Abdullaev, Z.
    Kaidarova, D. R.
    Kabysheva, N. P.
    INTERNATIONAL JOURNAL OF BIOLOGY AND CHEMISTRY, 2019, 12 (02): : 4 - 9
  • [29] BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
    Colombino, Maria
    Capone, Mariaelena
    Lissia, Amelia
    Cossu, Antonio
    Rubino, Corrado
    De Giorgi, Vincenzo
    Massi, Daniela
    Fonsatti, Ester
    Staibano, Stefania
    Nappi, Oscar
    Pagani, Elena
    Casula, Milena
    Manca, Antonella
    Sini, MariaCristina
    Franco, Renato
    Botti, Gerardo
    Caraco, Corrado
    Mozzillo, Nicola
    Ascierto, Paolo A.
    Palmieri, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2522 - 2529
  • [30] The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia
    Hussain, Syed Rizwan
    Babu, Sunil G.
    Naqvi, Hena
    Singh, Pradyumn
    Mahdi, Farzana
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (01) : 10 - 16